Eli Lilly extends tender offer to buy Point Biopharma
Dec 4 (Reuters) - Eli Lilly LLY.N on Monday extended
the deadline for the third time for Point Biopharma Global
PNT.O shareholders to sell their stock, due to low
participation.
The new deadline is Dec. 15.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi
Majumdar)
((Mariam.ESunny@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower